1523P Phase II Dose Optimization Results from MOUNTAINEER-02: A Study of Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel for HER2+ Gastroesophageal Cancer (GEC)
ANNALS OF ONCOLOGY(2023)
Key words
Trastuzumab
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined